Scarica l'app Stockscreener
5.00
0.40%
0.02
Trisalus Life Sciences Inc Borsa (TLSI) Ultime notizie
TriSalus Life Sciences (TLSI) Climbs 1.55% as Support Holds Above $4.99Wyckoff Distribution - vinanet.vn
TriSalus Life Sciences to Participate in the H.C. Wainwright & Company 28th Annual Global Investment Conference - Business Wire
TriSalus Life Sciences (TLSI) Slips 2% as Shares Test Key $4.59 Support LevelKey Reversal Day - dars.gov.et
TriSalus (TLSI) Results Review: The Bottom-Line Figure Trails Its Comparison in the Available Record; Share Response: Shares Move 3.04% Lower in the Latest SessionWeak Earnings Momentum - vinanet.vn
TriSalus (TLSI) Market: Falls 2.18% to $5.16 on the Day; Technical Setup: the Near-Term Reference Band Stretches From $4.90 to $5.42 on the DayETF NAV Deviation - vinanet.vn
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates - easternprogress.com
TriSalus (TLSI) Latest Quarter: The Bottom-Line Figure Trails Its Comparison for This Review; Price Move: Shares Finish 2.47% Up in the Current UpdateSegment Revenue Breakdown - vinanet.vn
TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference - MarketBeat
TriSalus Life Sciences (NASDAQ:TLSI) Cut to "Sell" at Wall Street Zen - MarketBeat
TriSalus Life Sciences Warrant (TLSIW) Plunges 55%: Critical Support Test at $0.53AAII Bullish - vinanet.vn
CCORF Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
TriSalus Life Sciences Inc (TLSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Trisalus Life Sciences at Canaccord Genuity: growth bets build By Investing.com - Investing.com Nigeria
Trisalus Life Sciences at Canaccord Genuity: growth bets build - Investing.com
TriSalus Life Sciences (TLSI) Advances 2.87% as Shares Hold Above $5.45 SupportETH Profile - dars.gov.et
Maxim Group Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Raises Target Price to $14 - Moomoo
TLSI Q2 2026 Earnings: EPS Misses Slightly as Liver-Tumor Focus ContinuesRetail Earnings Report - vinanet.vn
TriSalus Life Sciences (TLSI) Dips 4.3% to $5.37 as Shares Approach Key Support ZoneWedge Breakout - dars.gov.et
TriSalus Life Sciences earnings missed by $0.01, revenue topped estimates - Investing.com Canada
TriSalus Life Sciences (TLSI) Stock Surges As Losses Deepen Behind Strong Margins - Sahm
Securities Fraud Investigation Into TriSalus Life Sciences Inc - The National Law Review
TriSalus Life Sciences, Inc. (TLSI) stock price, news, quote and history - Yahoo Finance UK
TriSalus Life Sciences (NASDAQ:TLSI) Posts Quarterly Earnings Results, Meets Expectations - MarketBeat
TriSalus Life Sciences, Inc. Revenue Breakdown – NASDAQ:TLSIW - TradingView
TriSalus Life Sciences Q2 Earnings Call Highlights - marketbeat.com
Price to earnings forward of TriSalus Life Sciences, Inc. – NASDAQ:TLSIW - TradingView
TriSalus Life Sciences Inc (TLSI) (Q2 2026) Earnings Call Highlights: New CMS G-code Expands ... - Yahoo Finance
Earnings call transcript: TriSalus tops Q2 revenue forecast, stock slips after hours - Investing.com
Price to sales forward of TriSalus Life Sciences, Inc. – NASDAQ:TLSIW - TradingView
TriSalus Life Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
TLSI: Q2 revenue rose to $11.4M, with expanded OBL reimbursement and strong growth outlook - TradingView
TriSalus Q2 2026 Earnings: Gross Margin Rises as Operating Loss Widens - TradingKey
TriSalus Life Sciences, Inc. 2026: Revenue $11.41M, EPS ($0.16) — 10-Q Summary - TradingView
TriSalus Life Sciences Reports Second Quarter 2026 Results - marketscreener.com
Inside TriSalus Life Sciences (NASDAQ: TLSI) Q2 2026 performance - Stock Titan
TriSalus Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
TLSI: Q2 revenue up 1.7% to $11.4M, gross margin 88%, and 2026 guidance reaffirmed at $54–$57M - TradingView
TriSalus Life Sciences (TLSI) Gains 1.3% as Stock Holds Above Key SupportOutside Reversal - dars.gov.et
Earnings To Watch: TriSalus Life Sciences Inc (TLSI) Q2 2026 -- GF Value Sees 20% Upside - Yahoo Finance
TriSalus Life Sciences Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
TLSI Q1 2026 Earnings: Unexpected Profit of $0.03 Overwhelmingly Beats Loss EstimateOne-Time Gain Impact - vinanet.vn
TLSI Q1 2026 Earnings: EPS of $0.03 Beats Estimates with a 118.86% Positive SurpriseBalance Sheet Strength - vinanet.vn
TriSalus Life Sciences (TLSI) Stock Forum and Discussion - Moomoo
TriSalus Life Sciences Q1 2026 Earnings: EPS Surprise of 118.86% Beats Estimates Despite No Reported RevenueROA Comparison - dars.gov.et
TriSalus CEO and CFO to Join Canaccord Fireside Chat Aug. 12 - Stock Titan
TriSalus Life Sciences Inc (TLSI) Cash Flow - TradingKey
TriSalus Life Sciences Inc (TLSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
TriSalus Life Sciences Inc (TLSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TriSalus Life Sciences Inc (TLSI) Balance Sheet - TradingKey
First Light Asset Management LLC Invests $20.27 Million in TriSalus Life Sciences, Inc. $TLSI - MarketBeat
TriSalus Life Sciences Inc (TLSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TLSI Q1 2026 Earnings: Strong EPS Surprise as Company Focuses on PipelineLong-Term Guidance - dars.gov.et
TriSalus Life Sciences Inc (TLSI) Income Statement - TradingKey
TLSI|TriSalus Life Sciences Inc|Price:4.360|Chg%:+0.040 - TradingKey
TLSI|TriSalus Life Sciences Inc|Price:4.220|Chg%:-0.050 - TradingKey
TriSalus Life Sciences, Inc. Revenue Breakdown – NASDAQ:TLSI - TradingView
TriSalus Life Sciences Inc (TLSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TriSalus Life Sciences Initiates PREDICTT Clinical Trial - Medical Product Outsourcing
TriSalus Life Sciences (TLSI) Dips 2%: Testing Key Support Levels Amid Sector HeadwindsSector Leader Stocks - vinanet.vn
Lobbying Update: $90,000 of TRISALUS LIFE SCIENCES lobbying was just disclosed - Quiver Quantitative
TLSI Q1 2026 Earnings: EPS Surges Past Estimates, Stock Edges LowerManagement Tone Analysis - Vinanet
TriSalus Life Sciences Q1 2026 Earnings: Strong EPS Beat Surprises MarketGrowth Acceleration Report - vinanet.vn
Press Release: TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call - Moomoo
TriSalus Life Sciences to host Q2FY26 financial results call - scanx.trade
0.86%
0.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):